USD 16.18
(-4.94%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 209.1 Million USD | -25.32% |
2022 | 280 Million USD | 49.33% |
2021 | 187.5 Million USD | -24.64% |
2020 | 248.8 Million USD | -23.54% |
2019 | 325.4 Million USD | 31.37% |
2018 | 247.7 Million USD | -57.36% |
2017 | 580.9 Million USD | 0.33% |
2016 | 579 Million USD | 0.16% |
2015 | 578.1 Million USD | -9.13% |
2014 | 636.2 Million USD | 5246.22% |
2013 | 11.9 Million USD | -84.32% |
2012 | 75.9 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 218.3 Million USD | 1.68% |
2024 Q1 | 214.7 Million USD | 2.68% |
2024 Q3 | 162 Million USD | -7.38% |
2023 Q3 | 306.7 Million USD | 20.8% |
2023 Q4 | 209.1 Million USD | -31.82% |
2023 FY | 209.1 Million USD | -25.32% |
2023 Q1 | 255.4 Million USD | -8.79% |
2023 Q2 | 253.9 Million USD | -0.59% |
2022 Q3 | 304.2 Million USD | -0.56% |
2022 Q2 | 305.9 Million USD | -0.97% |
2022 Q1 | 308.9 Million USD | 64.75% |
2022 FY | 280 Million USD | 49.33% |
2022 Q4 | 280 Million USD | -7.96% |
2021 FY | 187.5 Million USD | -24.64% |
2021 Q2 | 227.4 Million USD | -5.33% |
2021 Q1 | 240.2 Million USD | -3.46% |
2021 Q3 | 205.8 Million USD | -9.5% |
2021 Q4 | 187.5 Million USD | -8.89% |
2020 Q3 | 320.2 Million USD | -0.77% |
2020 Q4 | 248.8 Million USD | -22.3% |
2020 Q1 | 321.3 Million USD | -1.26% |
2020 FY | 248.8 Million USD | -23.54% |
2020 Q2 | 322.7 Million USD | 0.44% |
2019 Q2 | 328 Million USD | 3.37% |
2019 FY | 325.4 Million USD | 31.37% |
2019 Q4 | 325.4 Million USD | 0.15% |
2019 Q3 | 324.9 Million USD | -0.95% |
2019 Q1 | 317.3 Million USD | 28.1% |
2018 Q2 | 247.4 Million USD | -54.35% |
2018 Q3 | 247.6 Million USD | 0.08% |
2018 Q4 | 247.7 Million USD | 0.04% |
2018 Q1 | 542 Million USD | -6.7% |
2018 FY | 247.7 Million USD | -57.36% |
2017 Q2 | 579.9 Million USD | 0.09% |
2017 Q1 | 579.4 Million USD | 0.07% |
2017 Q3 | 580.4 Million USD | 0.09% |
2017 Q4 | 580.9 Million USD | 0.09% |
2017 FY | 580.9 Million USD | 0.33% |
2016 Q4 | 579 Million USD | -1.76% |
2016 Q3 | 589.4 Million USD | -5.54% |
2016 Q2 | 624 Million USD | 7.87% |
2016 Q1 | 578.5 Million USD | 0.07% |
2016 FY | 579 Million USD | 0.16% |
2015 Q3 | 585.9 Million USD | 0.02% |
2015 FY | 578.1 Million USD | -9.13% |
2015 Q2 | 585.8 Million USD | -7.79% |
2015 Q1 | 635.3 Million USD | -0.14% |
2015 Q4 | 578.1 Million USD | -1.33% |
2014 Q1 | 9.4 Million USD | -21.01% |
2014 Q4 | 636.2 Million USD | 5736.7% |
2014 Q2 | 10.4 Million USD | 10.64% |
2014 FY | 636.2 Million USD | 5246.22% |
2014 Q3 | 10.9 Million USD | 4.81% |
2013 FY | 11.9 Million USD | -84.32% |
2013 Q4 | 11.9 Million USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | 75.9 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 98.683% |
Allurion Technologies Inc. | 41.85 Million USD | -399.558% |
Artivion, Inc. | 359.34 Million USD | 41.81% |
Butterfly Network, Inc. | 25.02 Million USD | -735.498% |
Butterfly Network, Inc. | 25.02 Million USD | -735.498% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 85.127% |
Boston Scientific Corporation | 9.49 Billion USD | 97.797% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | 78.906% |
Edwards Lifesciences Corporation | 694.9 Million USD | 69.909% |
Paragon 28, Inc. | 112.03 Million USD | -86.646% |
Glaukos Corporation | 383.73 Million USD | 45.51% |
Globus Medical, Inc. | 520.4 Million USD | 59.82% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -741.584% |
Integer Holdings Corporation | 1.04 Billion USD | 79.913% |
Medtronic plc | 26.04 Billion USD | 99.197% |
Nevro Corp. | 221.82 Million USD | 5.737% |
Owlet, Inc. | 15.21 Million USD | -1274.211% |
Penumbra, Inc. | 234.34 Million USD | 10.772% |
Vicarious Surgical Inc. | 14.83 Million USD | -1309.79% |
Smith & Nephew plc | 3.08 Billion USD | 93.22% |
Sonendo, Inc. | 40.35 Million USD | -418.203% |
STERIS plc | 3.38 Billion USD | 93.819% |
Stryker Corporation | 12.99 Billion USD | 98.391% |
Vapotherm, Inc. | 112.39 Million USD | -86.045% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 96.512% |